Caladrius Biosciences Inc (NASDAQ:CLBS) - Share price


Stock Report

Caladrius Biosciences Inc CLBS

Last Price
$0.52

Day Change
0.02|4.20%

As of 27/06/2022
19:42:06 EDT | USD
Minimum 15 Minutes Delay.

Last Close0.50
Day Range0.52 - 0.53
Mkt Cap31.55Mil
52-Wk Range0.40 - 1.66
Yield %-
ISINUS1280582032
Volume109,189
P/E-
P/S
P/CF-1.57

Share Price

Financials
201920202021
More ...
Income Statement
Revenue0.000.000.00
Operating Income-20.09-19.15-29.05
Net Income-19.36-8.15-27.47
Basic EPS-1.88-0.53-0.50
Avg. Diluted Shares Outstanding101555
Balance Sheet
Current Assets25.9735.3396.18
Non Current Assets1.180.670.83
Total Assets27.1536.0097.01
Current Liabilities5.983.514.52
Total Liabilities---
Total Equity20.8232.5092.25
Cash Flow
Operating Cash Flow-18.88-8.82-22.25
Capital Expenditure--0.02-0.06
Free Cash Flow--8.84-22.31

In millions, except "Basic EPS". Currency is USD.

Company Profile

Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its current product candidates include XOWNA, HONEDRA and CLBS201.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

27
Key Stats
More ...
Price/Earning TTM-1.32
Price/Book0.34
Price/Sales TTM
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % TTM-∞
Net Margin % TTM-∞
ROE TTM-44.03
Debt/Equity0.01
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.